Personalised Immunotherapy Platform — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Personalised Immunotherapy Platform — Stella

View on ClinicalTrials.gov

Recruiting

Back to Melanoma trials

Trial locations(3 sites)

Australia

Chris O'Brien Lifehouse, Sydney, New South Wales

Melanoma Institute Australia, Sydney, New South Wales

Westmead Hospital, Sydney, New South Wales

Key details

Sponsor

Melanoma Institute Australia

Enrollment target

~1,000 participants

Started

June 2021

Primary completion

June 2027

Age range

18 Years and older

Last updated September 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.